227 related articles for article (PubMed ID: 36293314)
41. Eukaryotic phosphatase inhibitors enhance colistin efficacy in gram-negative bacteria.
Barker WT; Jania LA; Melander RJ; Koller BH; Melander C
Chem Biol Drug Des; 2020 Nov; 96(5):1180-1186. PubMed ID: 32562384
[TBL] [Abstract][Full Text] [Related]
42. Distribution of macrolide, lincosamide, streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes in Gram-negative bacteria.
Roberts MC
Curr Drug Targets Infect Disord; 2004 Sep; 4(3):207-15. PubMed ID: 15379732
[TBL] [Abstract][Full Text] [Related]
43. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
[TBL] [Abstract][Full Text] [Related]
44. In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.
Sato T; Tateda K; Kimura S; Iwata M; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2011 Apr; 55(4):1588-93. PubMed ID: 21220534
[TBL] [Abstract][Full Text] [Related]
45. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
[TBL] [Abstract][Full Text] [Related]
46. Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.
Veloo Y; Thahir SSA; Rajendiran S; Hock LK; Ahmad N; Muthu V; Shaharudin R
Microbiol Spectr; 2022 Jun; 10(3):e0269421. PubMed ID: 35467407
[TBL] [Abstract][Full Text] [Related]
47. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens.
Kumar V; Yasmeen N; Pandey A; Ahmad Chaudhary A; Alawam AS; Ahmad Rudayni H; Islam A; Lakhawat SS; Sharma PK; Shahid M
Front Cell Infect Microbiol; 2023; 13():1293633. PubMed ID: 38179424
[TBL] [Abstract][Full Text] [Related]
49. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria.
Otsuka Y
Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524
[TBL] [Abstract][Full Text] [Related]
50. Recent Advancements in Macrolide Hybrids against Staphylococcus aureus.
Ji C; Xu X
Curr Top Med Chem; 2021; 21(27):2455-2473. PubMed ID: 33272187
[TBL] [Abstract][Full Text] [Related]
51. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon R; Idowu T; Zhanel GG; Schweizer F
Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434
[TBL] [Abstract][Full Text] [Related]
52. Treatment of Gram-negative bacterial infections by potentiation of antibiotics.
Zabawa TP; Pucci MJ; Parr TR; Lister T
Curr Opin Microbiol; 2016 Oct; 33():7-12. PubMed ID: 27232956
[TBL] [Abstract][Full Text] [Related]
53. Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.
Luna BM; Ershova K; Yan J; Ulhaq A; Nielsen TB; Hsieh S; Pantapalangkoor P; Vanscoy B; Ambrose P; Rudin S; Hujer K; Bonomo RA; Actis L; Skaar EP; Spellberg B
J Antimicrob Chemother; 2019 Sep; 74(9):2631-2639. PubMed ID: 31170282
[TBL] [Abstract][Full Text] [Related]
54. Rejuvenating the Activity of Usual Antibiotics on Resistant Gram-Negative Bacteria: Recent Issues and Perspectives.
Tabcheh J; Vergalli J; Davin-Régli A; Ghanem N; Pages JM; Al-Bayssari C; Brunel JM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675027
[TBL] [Abstract][Full Text] [Related]
55. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
Annunziato G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
[TBL] [Abstract][Full Text] [Related]
56. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
57. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
Dombach JL; Quintana JLJ; Detweiler CS
mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
[TBL] [Abstract][Full Text] [Related]
58. Synergy of outer membrane disruptor SLAP-S25 with hydrophobic antibiotics against Gram-negative pathogens.
Yang Z; Song M; Li X; Zhang Q; Shen J; Zhu K
J Antimicrob Chemother; 2022 Dec; 78(1):263-271. PubMed ID: 36385317
[TBL] [Abstract][Full Text] [Related]
59. Macrolide Resistance in
Schroeder MR; Stephens DS
Front Cell Infect Microbiol; 2016; 6():98. PubMed ID: 27709102
[No Abstract] [Full Text] [Related]
60. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
